Model
Edge
Regeneron Pharmaceuticals, Inc.
0001697422
Filing type
144
Filing date
Feb 8, 2024
Updated
Feb 9, 2024 ยท 5:22 AM
Copy reference
Filing
144
Notice of Proposed Sale of Securities